PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE/Dazzle™ 594 anti-mouse CD64 (FcγRI), 25 μg
PE/Dazzle™ 594 anti-mouse CD69, 100 μg
PE/Dazzle™ 594 anti-mouse CD69, 25 μg
PE/Dazzle™ 594 anti-mouse CD80, 100 μg
PE/Dazzle™ 594 anti-mouse CD80, 25 μg
PE/Dazzle™ 594 anti-mouse CD86, 100 μg
PE/Dazzle™ 594 anti-mouse CD86, 25 μg
PE/Dazzle™ 594 anti-mouse CD8a, 100 μg
PE/Dazzle™ 594 anti-mouse CD8a, 25 μg
PE/Dazzle™ 594 anti-mouse CD8b (Ly-3), 100 μg
PE/Dazzle™ 594 anti-mouse CD8b (Ly-3), 25 μg
PE/Dazzle™ 594 anti-mouse CD90.2 (Thy1.2), 100 μg
PE/Dazzle™ 594 anti-mouse CD90.2 (Thy1.2), 25 μg
PE/Dazzle™ 594 anti-mouse CD90.2, 100 μg
PE/Dazzle™ 594 anti-mouse CD90.2, 25 μg
PE/Dazzle™ 594 anti-mouse CX3CR1, 100 μg